“Quality of Life in Patients with Metastatic or Unresectable Melanoma: Is Monotherapy with Nivolumab Preferred Over Combination Therapy?”, Rev Med Trujillo, vol. 19, nº 3, p. 092–097, set. 2024, doi: 10.17268/rmt.2024.v19i3.6141.